Repurposing approved drugs on the pathway to novel therapies

Keyphrases

• Antibiotics 100%
• Human Use 100%
• Novel Therapies 100%
• Approved Drugs 100%
• Repurposing Approved Drugs 100%
• Virus 50%
• Inflammation 50%
• Host Cell 50%
• Emerging Infectious Diseases 50%
• Cell Signaling Pathways 50%
• Response to Injury 50%
• Tumor Necrosis Factor-α 50%
• New Drugs 50%
• Autophagy 50%
• Physicochemical Properties 50%
• In Cancer 50%
• Interferon-α (IFN-α) 50%
• Mode of Action 50%
• New Targets 50%
• Cytokine Storm 50%
• Clinical Efficacy 50%
• Cancer Disease 50%
• Scar 50%
• Cancer Therapy 50%
• Injury Control 50%
• Thalidomide 50%
• Bacterial Toxins 50%
• Synergistic Interaction 50%
• Severely Ill Patients 50%
• Multidrug Resistance 50%
• Rare Diseases 50%
• Inpatient Treatment 50%
• Low Water Solubility 50%
• Low Reactivity 50%
• Drug Repurposing 50%
• Medicinal Chemist 50%
• Bacterial Enzymes 50%
• Active Pharmaceutical Ingredients 50%
• Storm Response 50%
• Trial Sequential Analysis 50%
• Controlled Infection 50%
• Antibiotic-resistant Organisms 50%
• Patients with Comorbidities 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Repurposing 100%
• Side Effect 100%
• Antibiotics 66%
• Malignant Neoplasm 33%
• Infection 33%
• Inflammation 33%
• Antiviral Drug 33%
• Tumor Necrosis Factor 33%
• Cytokine Storm 33%
• Interferon 33%
• Thalidomide 33%
• Scar Formation 33%
• Bacterial Toxin 33%
• Tumor Virus 33%
• Rare Disease 33%
• Bacterial Enzyme 33%
• Comorbidity 33%
• Antimicrobial Agent 33%
• Multidrug Resistance 33%
• Mode of Action 33%